No relief: AFT appeals Reckitt-Benckiser win over Maxigesic ads
Alastair Vincent 2020-10-21 4:12 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

The maker of pain killer Maxigesic is taking its long-running battle with Nuromol manufacturer Reckitt Benckiser to an appeals court after a recent ruling that its advertising misled consumers by claiming Maxigesic provided better, faster and more effective pain relief than paracetamol or ibuprofen.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au